NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.16 billion as of March 9, 2026. Its market cap has decreased by -24.00% in one year.

Market Cap

1.16B

Enterprise Value

1.41B

1-Year Change

-24.00%

Ranking

#2430

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.16B, an increase of 14,557.28%. That is a compound annual growth rate of 25.46%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	1.16B	-23.56%
Dec 31, 2025	1.52B	-28.07%
Dec 31, 2024	2.12B	2.57%
Dec 29, 2023	2.06B	76.73%
Dec 30, 2022	1.17B	-72.22%
Dec 31, 2021	4.20B	-29.72%
Dec 31, 2020	5.98B	95.74%
Dec 31, 2019	3.05B	160.37%
Dec 31, 2018	1.17B	64.64%
Dec 29, 2017	712.40M	5.87%
Dec 30, 2016	672.90M	41.66%
Dec 31, 2015	475.00M	89.92%
Dec 31, 2014	250.10M	41.06%
Dec 31, 2013	177.30M	57.88%
Dec 31, 2012	112.30M	85.62%
Dec 30, 2011	60.50M	24.49%
Dec 31, 2010	48.60M	-12.90%
Dec 31, 2009	55.80M	189.12%
Dec 31, 2008	19.30M	-43.07%
Dec 31, 2007	33.90M	-16.30%
Dec 29, 2006	40.50M	841.86%
Dec 30, 2005	4.30M	-20.37%
Dec 31, 2004	5.40M	-31.65%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Twist Bioscience	2.88B
Veracyte	2.69B
GeneDx Holdings	2.58B
Neogen	2.11B
GRAIL	2.03B
CareDx	916.26M
OPKO Health	895.70M
Personalis	820.31M

Market Cap Rankings